載入...
A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer
OBJECTIVE: We performed this meta-analysis to compare the efficacy and toxicity of regorafenib and TAS-102. METHODS: Electronic databases were searched to identify studies comparing the efficacy and safety of regorafenib and TAS-102 in patients with chemotherapy-refractory metastatic colorectal canc...
Na minha lista:
| 發表在: | J Int Med Res |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361493/ https://ncbi.nlm.nih.gov/pubmed/32660291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520926408 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|